MRD / Regn No. : 20260000588 Date : 30/06/2026
Patient Name : Kripa Ram Das Age & Gender : 67 Yrs. / Male
Contact No. : 9435124507 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Subjective : DM FOR 20 YEARS
Objective : INJECTION SITE REACTION
Analysis : TYPE 2 DM,ANEMIA,VITAMIN D INSUFFICEINCY
Plan : GET ADDITIONAL TESTING FOR ANEMIA,CHANGE TO SEMAGLUTIDE AND SGLT2I  
Salient Investigations : ECG ELECTROCARDIOGRAM DESCRIPTIVE: RVH | QTC INTERVAL: 435 sec
S# Generic (Trade) Name Route Dosage Usage Duration
1 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
2 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
3 INJECTION SEMAGLUTIDE
SUNDAE 0.25 MG
Medicine For DIABETES OBESITY
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING AND VISUAL DISTURBANCES
4 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
       
Refill : 0 / Substitution:    
Education :
Next Visit : 01/Jul/2026
Tests Suggested For Next Visit : IRON TIBC VITAMIN B12 FERRITIN STOOL OCCULT BLOOD
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: